BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7083692)

  • 1. Skeletal metastases of unknown origin. Diagnostic strategy for orthopedic surgeons.
    Simon MA; Karluk MB
    Clin Orthop Relat Res; 1982 Jun; (166):96-103. PubMed ID: 7083692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal metastases of unknown origin: a retrospective analysis of 29 cases.
    Jacobsen S; Stephensen SL; Paaske BP; Lie PG; Lausten GS
    Acta Orthop Belg; 1997 Mar; 63(1):15-22. PubMed ID: 9151454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
    Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
    Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy.
    Rougraff BT; Kneisl JS; Simon MA
    J Bone Joint Surg Am; 1993 Sep; 75(9):1276-81. PubMed ID: 8408149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The search for the primary tumor in patients with skeletal metastases of unknown origin.
    Simon MA; Bartucci EJ
    Cancer; 1986 Sep; 58(5):1088-95. PubMed ID: 3015375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features of pathologically confirmed metastatic bone tumors--a report of 390 cases].
    Xu DL; Zhang XT; Wang GH; Li FB; Hu JY
    Ai Zheng; 2005 Nov; 24(11):1404-7. PubMed ID: 16552972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone metastasis as a sign of the existence of latent neoplasia].
    Dallari R; Gazzotti GL; Barozzini P; Cervi F; Cavani R
    Minerva Med; 1986 May; 77(22-23):981-7. PubMed ID: 3014381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological evaluation of metastatic carcinomas of bone : a retrospective analysis of 114 cases over 10 years.
    Desai S; Jambhekar N
    Indian J Pathol Microbiol; 1995 Jan; 38(1):49-54. PubMed ID: 8919469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of bone metastases from renal cell carcinoma].
    Tsuda S; Koga S; Nishikido M; Tsurusaki T; Igawa T; Noguchi M; Kanda S; Matsuya F; Kanetake H
    Hinyokika Kiyo; 2001 Mar; 47(3):155-8. PubMed ID: 11329954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma.
    Schapira DV; Jarrett AR
    Arch Intern Med; 1995 Oct; 155(19):2050-4. PubMed ID: 7575063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging to detect bone marrow metastases in the initial staging of small cell lung carcinoma and breast carcinoma.
    Layer G; Steudel A; Schüller H; van Kaick G; Grünwald F; Reiser M; Schild HH
    Cancer; 1999 Feb; 85(4):1004-9. PubMed ID: 10091781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Unknown primary bone metastasis: therapeutic and diagnostic strategies].
    Bortolus R; Roncadin M; Arcicasa M; Boz G; Franchin G; De Paoli A; Falchi AM; Trovó MG
    Radiol Med; 1993 Apr; 85(4):406-10. PubMed ID: 8516467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen for diagnosis of bone metastases in patients with primary lung cancer.
    Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M
    Respirology; 2005 Jun; 10(3):300-4. PubMed ID: 15955141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of biopsy of new bone lesions in patients with previous carcinoma.
    Clayer M; Duncan W
    Clin Orthop Relat Res; 2006 Oct; 451():208-11. PubMed ID: 16801861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma.
    Sengeløv L; Kamby C; von der Maase H
    J Urol; 1996 Jan; 155(1):111-4. PubMed ID: 7490804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumor markers in skeletal metastasis.
    Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
    Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
    Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup.
    Waltonen JD; Ozer E; Hall NC; Schuller DE; Agrawal A
    Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1024-9. PubMed ID: 19841343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic strategies in cervical carcinoma of an unknown primary (CUP).
    Haas I; Hoffmann TK; Engers R; Ganzer U
    Eur Arch Otorhinolaryngol; 2002 Jul; 259(6):325-33. PubMed ID: 12115082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.